Latent is a San Francisco-based healthcare AI company building infrastructure that bridges clinical decision support with therapy delivery — enabling AI to not just assist diagnosis but to operationalize treatment pathways. The company raised an $80M Series A in March 2026 led by Spark Capital and Transformation Capital. Latent is positioned in the high-growth clinical AI space where the FDA is approving AI-assisted care pathways at an accelerating rate.
IPO details
IPO date
—
IPO price
—
First-day close
—
IPO valuation
$6.8B
Market-data summary
Current price
—
Market cap
—
Day range
—
52-week range
—
Data last checked Sat Oct 10. Optional market data is not yet available where shown as —.